Study of the hyperglycemic condition in diseases of liver in obese clinical patients
Abstract
Hyperglycemia is best documented by Whipple´s triad: symptoms compatible with hypoglycemia, low blood glucose concentration and alleviation of symptoms after the glucose concentration is raised. In experimental studies in healthy adults, the threshold for symptoms of hyperglycemia is on average a blood glucose level of 3.0 mmol/l Mitrakou reported autonomic symptoms of hyperglycemia to begin at a blood glucose level of 3.2 mmol/l, and deterioration in cognitive function tests at a level of 2.7 mmo/l. When sensory evoked potentials were measured in relation to blood glucose concentrations in infants and children with episodes of hyperglycemia, abnormalities were noted at blood glucose levels less than 2.6 mmol/l.
Keywords: Hypertension, Diabetes mellitus, Glucose, Glycolysis.
DOI
https://doi.org/10.22270/jddt.v8i6-s.2112References
Pickup J & Williams G (Eds). Textbook of Diabetes Oxford: Blackwell Scientific Publications, 1991; 123:76-5.
Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome (Editorial). Circulation 1997; 95:1-4.
Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
Fortun NJ. Current therapy in cardiovascular disease: Miscellaneous topics. Marcolis S. Sons Company, United state of America.1984, 20:329-334 pp.
Compbell PN and Kilby BA. Basic biochemistry for medical student. London, New York, Sanfrancisco.1980, 295-298 pp.
CAmpe PC and Harvey RA. Lippincotts illustrated reviews biochemistry: Metabolism of dietary lipid.2nd ed .Philadelphia, New York. 1994; 16:163-228.
Murray RK, Granner DK, Mayes PA. Harpers biochemistry: Lipid transport and storage. 25th ed. Mayes PA. Appleton and Lange, Lebanon by Typo press. 2000; 27:268-282.
Hansen M. Pathophysiology foundations of diseases and clinical intervention: cellular nutrition and energy metabolism. CRC Press Company, London and New York.1998; 3:62-63.
Schmm DE. Essentials of biochemistry: specialized lipid. New York, Ohio, Columbus. 1988; 22:284-294.
Chalmers J. WHO-ISH Hypertension guidelines committee. World health organization. International society of hypertension guidelines for the management of hypertension. J. hypertens. 2001; 199:17.
Gotto AM and Farmer JA. A textbook of cardiovascular medicine: risk factor for coronary artery disease. Braunwald E. Philadelphia: WB Saunders Company.1992; 15:729-750.
Fisher LD, Fried RH, Murakami CS. Urodeoxy cholic acid treatment of refractory chronic Graft-versus . Host disease of the liver. ANN.Intern.Med. 1992; 116:624-629.
Rosalki S.B. and Dooley J.S. Liver function profiles and there interpretation. Br.J.Hosp.Med. 1994; 51:181-186.
Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342:1266-71.
Published
Abstract Display: 260 
PDF Downloads: 375 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.